Abstract:Recently, molecular generation models based on deep learning have attracted significant attention in drug discovery. However, most existing molecular generation models have serious limitations in the context of drug design wherein they do not sufficiently consider the effect of the three-dimensional (3D) structure of the target protein in the generation process. In this study, we developed a new deep learning-based molecular generator, SBMolGen, that integrates a recurrent neural network, a Monte Carlo tree search, and docking simulations. The results of an evaluation using four target proteins (two kinases and two G protein-coupled receptors) showed that the generated molecules had a better binding affinity score (docking score) than the known active compounds, and the generated molecules possessed a broader chemical space distribution. SBMolGen not only generates novel binding active molecules but also presents 3D docking poses with target proteins, which will be useful in subsequent drug design. The code is available at <a class="extLink" href="https://github.com/clinfo/SBMolGen">https://github.com/clinfo/SBMolGen</a>.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.1c00679?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.1c00679</a>.Number of generated molecules, example of generated molecules for target EGFR at C = 1.0, example of generated molecules for target AA2AR at C = 1.0, example of generated molecules for target ADRB2 at C = 1.0; distribution of the similarity score of the generated molecules and distribution of the scaffold similarity score of the generated molecules; distribution of the SA scores of the generated molecules; distributions of the QED scores of the generated molecules; plots of IFIE<sub>sum</sub> against experimentally determined Δ<i>G</i> for (A) nine CDK2 inhibitors and (B) generated molecules; distribution of the docking scores of the generated molecules against DDR1; chemical structures of nine CDK2 inhibitors and their properties (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.1c00679/suppl_file/ci1c00679_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Systems-Structure-Based Drug Design

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

A Systematic Survey in Geometric Deep Learning for Structure-based Drug Design

Deep Learning in Structure-Based Drug Design

Structure-Based Drug Design with a Deep Hierarchical Generative Model

Computational Methods for Structure-Based Drug Design Through System Biology.

De Novo Structure-Based Drug Design Using Deep Learning

Systems Biology Brings New Dimensions for Structure-Based Drug Design

BInD: Bond and Interaction-generating Diffusion Model for Multi-objective Structure-based Drug Design

RELATION: A Deep Generative Model for Structure-Based De Novo Drug Design

DrugHIVE: Target-specific spatial drug design and optimization with a hierarchical generative model

A Simple Way to Incorporate Target Structural Information in Molecular Generative Models

Fragment-Based Ligand Generation Guided By Geometric Deep Learning On Protein-Ligand Structure

Structure-Based de Novo Molecular Generator Combined with Artificial Intelligence and Docking Simulations

Towards Structure-Based Protein Drug Design

Deep generative model for drug design from protein target sequence

DrugGen: Advancing Drug Discovery with Large Language Models and Reinforcement Learning Feedback

Synthesis-driven design of 3D molecules for structure-based drug discovery using geometric transformers

Structure-based <i>de novo</i> drug design using 3D deep generative models

Structure-based drug design with geometric deep learning

Innovative Drug-like Molecule Generation from Flow-based Generative Model